References
- Al-AroujMAssaad–KhalilSBuseJRecommendations for management of diabetes during RamadanDiabetes Care20103381895190220668157
- SaltiIBénardEDetournayBEPIDIAR Study GroupA population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) studyDiabetes Care200427102306231115451892
- KulSSavaşEÖztürkZAKaradağGDoes Ramadan fasting alter body weight and blood lipids and fasting blood glucose in a healthy population? A meta-analysisJ Relig Health201453392994223423818
- MuchaGTMerkelSThomasWBantleJPFasting and insulin glargine in individuals with type 1 diabetesDiabetes Care20042751209121015111549
- SaltiIDiabetes and Ramadan Study GroupEfficacy and safety of insulin glargine and glimepiride in subjects with Type 2 diabetes before, during and after the period of fasting in RamadanDiabet Med200926121255126120002478
- ChentliFAzzougSAmani MelAElgradechiADiabetes mellitus and Ramadan in AlgeriaIndian J Endocrinol Metab201317Suppl 1S295S29824251192
- ElmehdawiRRMukhtadNAAllaghiNIElmajberiSJFasting of Ramadan in peoples with diabetes in Benghazi, Libya: an exploratory studyLibyan J Med2010550365040
- AhmedaniMYAlviSFHaqueMSFawwadABasitAImplementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from PakistanJ Diabetes Metab Disord20141313724559109
- LokeSCRahimKFKanesvaranRWongTWA prospective cohort study on the effect of various risk factors on hypoglycemia in diabetes who fast during RamadanMed J Malaysia20106513621265238
- MnifFSlamaCBChaiebLBlouzaSHsairiMAbidMObservational study of the Tunisian diabetic patients’ profile during the fasting of the holy month of RamadanJ Endocrinol Diab20163418
- CesurMCorapciogluDGursoyAA comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fastingDiabetes Res Clin Pract200775214114716815586